Home/Filings/4/0001104659-26-001484
4//SEC Filing

HENDERSON MICHAEL THOMAS 4

Accession 0001104659-26-001484

CIK 0001974640other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 8:01 PM ET

Size

5.7 KB

Accession

0001104659-26-001484

Insider Transaction Report

Form 4
Period: 2026-01-02
HENDERSON MICHAEL THOMAS
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-02+253,016253,016 total
    Exercise: $75.78Exp: 2036-01-02Common Stock (253,016 underlying)
Footnotes (1)
  • [F1]This option represents the right to purchase 253,016 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.

Issuer

Apogee Therapeutics, Inc.

CIK 0001974640

Entity typeother

Related Parties

1
  • filerCIK 0001779990

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 8:01 PM ET
Size
5.7 KB